Bristol-Myers Squibb Co (BMY)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

430 E. 29TH STREET NEW YORK, NY 10016

Bristol-Myers Squibb Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals and other healthcare-related products. The Company has three segments: Pharmaceuticals, Nutritionals and ConvaTec. The Pharmaceuticals segment is made up of the global pharmaceutical and international consumer medicines business. The other two segments Nutritionals and ConvaTec comprise the Company's Health Care Group. The Nutritionals segment consists of Mead Johnson Nutritionals (Mead Johnson), primarily an infant formula and children's nutritionals business. The ConvaTec segment consists of the ostomy, wound and skin care business.

Data as of 2020-08-09
Market Cap137.535 Billion Shares Outstanding2.254 Billion Avg 30-day Volume10.708 Million
P/E Ratio98.4 Dividend Yield2.95 EPS0.62
Price/Sales5.561 Price cash flow ratio9.7 Price free cash flow ratio-40.3
Book Value21.78 Price to Tangible Book-4.02 Alpha-0.0
Short Interest Ratio1.49 % Short Interest to Float1.0 R-squared0.149543
BETA0.692316 52-week High/Low68.34 / 45.32 Stddev0.075283
View SEC Filings from BMY instead.
Q1 2020 All Institutions Hedge Funds 1
Filers who had this stock in their top 10: 119 32 (2.1%)
13F Filers holding this stock: 2058 326 (21.35%)
Aggregate 13F shares on 03/31/2020: 1.676 Billion 608.641 Million
Aggregate 13F shares on 12/31/2019: 1.761 Billion 599.763 Million
Percent change: -4.82% 1.48%
Funds creating new positions: 145 35
Funds Adding to an existing position: 782 128
Funds closing out their position: 178 48
Funds reducing their position: 913 133
Heat Map Ranking for 03/31/2020 113
Heat Map Ranking for 12/31/2019 92
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding BMY (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding BMY BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

9.2 Thousand total shares from 1 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

57.9 Thousand total shares from 5 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

WILLIAMS R SANDERS

  • Director
5,159 2020-08-07 0

ELKINS DAVID V EVP, CHIEF FINANCIAL OFFICER

  • Officer
54,977 2020-08-01 8

SANTIAGO KAREN MURPHY SVP & CONTROLLER

  • Officer
7,748 2020-07-01 3

HIRAWAT SAMIT EVP,CHIEF MED.OFFR.,DRUG DEV.

  • Officer
4,893 2020-07-01 2

BONNEY MICHAEL W

  • Director
0 2020-07-01 11

GROBSTEIN MICHAEL

  • Director
0 2020-06-30 5

BANCROFT CHARLES A

  • Director
0 2020-06-30 2

STORCH GERALD L

  • Director
0 2020-06-30 5

LACY ALAN J

  • Director
0 2020-06-30 5

PALIWAL DINESH C

  • Director
0 2020-06-30 6

ARDUINI PETER J

  • Director
0 2020-06-30 5

SAMUELS THEODORE R. II

  • Director
0 2020-06-30 5

EMMENS MATTHEW

  • Director
0 2020-06-30 5

BERTOLINI ROBERT J

  • Director
0 2020-06-30 5

VOUSDEN KAREN H

  • Director
0 2020-06-30 5

HALLER JULIA A

  • Director
0 2020-06-30 9

YALE PHYLLIS R

  • Director
0 2020-06-30 6

SATO VICKI L

  • Director
0 2020-06-25 1

BIONDI PAUL

  • Director
0 2020-06-18 1

HOOPER ANTHONY C

  • Director
0 2020-06-17 0

EID JOSEPH SVP,HEAD GLOB. MEDICAL AFFAIRS

  • Officer
7,861 2020-06-03 4

DUBOW ADAM SVP,CHIEFCOMPLIANCE&ETHICSOFF.

  • Officer
17,023 2020-05-22 3

CUSS FRANCIS M

  • Director
0 2020-05-21 0

SCHMUKLER LOUIS S EVP,PRES.,GLOB.PROD. & SUPPLY

  • Officer
26,777 2020-05-19 3

JOHANSSON LEIF

  • Director
16,293 2020-05-07 0

GORDON MURDO EVP GLOBAL COMMERCIAL OPS

  • Officer
37,873 2020-05-05 0

AHMED NADIM EVP AND PRESIDENT, HEMATOLOGY

  • Officer
27,996 2020-05-01 9

VESSEY RUPERT EVP, RESEARCH & EARLY DEV.

  • Officer
54,389 2020-05-01 11

ANDREOTTI LAMBERTO

  • Director
20,923 2020-04-28 0

MILY ELIZABETH EVP, STRATEGY & BD

  • Officer
0 2020-04-01 3

LEUNG SANDRA EVP, GENERAL COUNSEL

  • Officer
580,563 2020-03-10 1

CAFORIO GIOVANNI CHAIRMAN AND CEO

  • Officer
  • Director
485,424 2020-03-10 2

VON AUTENRIED PAUL EVP, CHIEF INFORMATION OFFICER

  • Officer
146,701 2020-03-10 1

ELICKER JOHN E EVP, INVESTOR RELATIONS

  • Officer
70,946 2020-03-10 3

POWELL ANN EVP, CHIEF HUMAN RESOURCES

  • Officer
51,452 2020-03-10 1

BOERNER CHRISTOPHER S. EVP, CHIEF COMMERCIAL OFFICER

  • Officer
21,033 2020-03-10 2

METCALFE KATHRYN EVP, CORPORATE AFFAIRS

  • Officer
0 2020-03-10 3

DANIELS BRIAN

  • Director
0 2020-02-11 0

CELENTANO JOHN E

  • Director
0 2020-01-02 0

GLIMCHER LAURIE H M.D.

  • Director
4,067 2020-01-02 0

LEVIN JEREMY M CEO

  • Officer
  • Director
  • 10% Owner
0 2019-12-18 0

SIGAL ELLIOT

  • Director
0 2019-12-17 0

LYNCH THOMAS J. JR. EVP & CHIEF SCIENTIFIC OFFICER

  • Officer
22,223 2019-04-03 0

BASELGA JOSE

  • Director
No longer subject to file 2018-09-30 0

STORCH GERALD L

STORCH GERALD L

  • Director
0 2018-09-30 5

ROBINSON JAMES D III

  • Director
  • 10% Owner
8,710,679 2018-05-29 0

HELLER FRANCES K

  • Director
47,961 2017-10-13 0

CALDARELLA JOSEPH C SVP & CONTROLLER

  • Officer
48,076 2017-09-06 0

NIELSEN ANNE CHIEF COMPLIANCE & ETHICS OFF

  • Officer
37,974 2017-09-03 0

CORNELIUS JAMES M

  • Director
No longer subject to file 2017-06-15 0

WEST TOGO D JR

  • Director
0 2017-04-06 0

BLIN EMMANUEL SVP, CHIEF STRATEGY OFFICER

  • Officer
20,138 2017-03-10 0

CAMPBELL LEWIS B

  • Director
2,110 2016-03-08 0

MOED SAMUEL J SVP, STRAT PLAN & ANALYSIS

  • Officer
31,615 2015-03-13 0

CAZALA BEATRICE J EVP COMMERCIAL OPERATIONS

  • Officer
177,118 2013-05-31 0

FREEH LOUIS J

  • Director
0 2013-02-01 0

CARLO DE NOTARISTEFANI PRES TECH OPS & SUPP FNCTNS

  • Officer
8,432 2011-06-14 0

ZITO ROBERT T SVP & CHIEF COMM OFFICER

  • Officer
35,469 2010-03-06 0

MCBRIDE ANTHONY A SVP HUMAN RESOURCES

  • Officer
34,292 2010-03-06 0

HUET JEAN-MARC EVP & CFO

  • Officer
25,000 2009-04-30 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

ELKINS DAVID V - Officer EVP, CHIEF FINANCIAL OFFICER

2020-08-01 M 46,402 a 80,698 54,977.00 direct

ELKINS DAVID V - Officer EVP, CHIEF FINANCIAL OFFICER

2020-08-01 M 46,402 d 46,403 54,977.00 direct

ELKINS DAVID V - Officer EVP, CHIEF FINANCIAL OFFICER

2020-08-01 F 25,916 $58.66 d 54,782 54,977.00 direct

HIRAWAT SAMIT - Officer EVP,CHIEF MED.OFFR.,DRUG DEV.

2020-07-01 M 9,356 a 9,356 4,893.00 direct

SANTIAGO KAREN MURPHY - Officer SVP & CONTROLLER

2020-07-01 M 1,069 a 8,115 7,748.00 direct

HIRAWAT SAMIT - Officer EVP,CHIEF MED.OFFR.,DRUG DEV.

2020-07-01 M 9,356 d 28,069 4,893.00 direct

SANTIAGO KAREN MURPHY - Officer SVP & CONTROLLER

2020-07-01 M 1,069 d 3,208 7,748.00 direct

HIRAWAT SAMIT - Officer EVP,CHIEF MED.OFFR.,DRUG DEV.

2020-07-01 F 4,463 $59.43 d 4,893 4,893.00 direct

SANTIAGO KAREN MURPHY - Officer SVP & CONTROLLER

2020-07-01 F 367 $59.43 d 7,748 7,748.00 direct

HALLER JULIA A - Director

2020-06-30 A 529 $58.80 a 4,931 0.00 direct

BERTOLINI ROBERT J - Director

2020-06-30 A 595 $58.80 a 21,385 0.00 direct

YALE PHYLLIS R - Director

2020-06-30 A 489 $58.80 a 4,891 0.00 direct

ARDUINI PETER J - Director

2020-06-30 A 617 $58.80 a 26,664 0.00 direct

SAMUELS THEODORE R. II - Director

2020-06-30 A 553 $58.80 a 20,049 0.00 direct

PALIWAL DINESH C - Director

2020-06-30 A 659 $58.50 a 34,744 0.00 direct

STORCH GERALD L - Director

2020-06-30 A 579 $58.80 a 57,606 0.00 direct

GROBSTEIN MICHAEL - Director

2020-06-30 A 114 $58.80 a 87,898 0.00 direct

VOUSDEN KAREN H - Director

2020-06-30 A 165 $58.80 a 14,077 0.00 direct

EMMENS MATTHEW - Director

2020-06-30 A 617 $58.80 a 21,668 0.00 direct

LACY ALAN J - Director

2020-06-30 A 213 $58.80 a 78,952 0.00 direct

BONNEY MICHAEL W - Director

2020-06-30 A 392 $58.80 a 4,639 0.00 direct

PALIWAL DINESH C - Director

2020-06-15 P 9,174 $54.50 a 22,109 22,109.35 direct

BONNEY MICHAEL W - Director

2020-06-14 M 558 a 8,650 10,650.00 direct

HALLER JULIA A - Director

2020-06-14 M 558 a 6,819 6,819.00 direct

BONNEY MICHAEL W - Director

2020-06-14 M 558 d 0 10,650.00 direct

HALLER JULIA A - Director

2020-06-14 M 558 d 0 6,819.00 direct
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments